S08

2-(6-(((R)-2-amino-2-oxo-1-phenylethyl)carbamoyl)-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-3-yl)acetic acid

Created:	2020-11-04
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where S08 is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	44
Chiral Atom Count	2
Bond Count	46
Aromatic Bond Count	12

2D diagram of S08

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2-(6-(((R)-2-amino-2-oxo-1-phenylethyl)carbamoyl)-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-3-yl)acetic acid
Synonyms	2-[(3S)-6-[[(1R)-2-azanyl-2-oxidanylidene-1-phenyl-ethyl]carbamoyl]-1-oxidanyl-3H-2,1-benzoxaborol-3-yl]ethanoic acid
Systematic Name (OpenEye OEToolkits)	2-[(3~{S})-6-[[(1~{R})-2-azanyl-2-oxidanylidene-1-phenyl-ethyl]carbamoyl]-1-oxidanyl-3~{H}-2,1-benzoxaborol-3-yl]ethanoic acid
Formula	C₁₈ H₁₇ B N₂ O₆
Molecular Weight	368.148
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	NC(=O)[CH](NC(=O)c1ccc2[CH](CC(O)=O)OB(O)c2c1)c3ccccc3
SMILES	OpenEye OEToolkits	2.0.7	B1(c2cc(ccc2C(O1)CC(=O)O)C(=O)NC(c3ccccc3)C(=O)N)O
Canonical SMILES	CACTVS	3.385	NC(=O)[C@H](NC(=O)c1ccc2[C@H](CC(O)=O)OB(O)c2c1)c3ccccc3
Canonical SMILES	OpenEye OEToolkits	2.0.7	B1(c2cc(ccc2[C@@H](O1)CC(=O)O)C(=O)N[C@H](c3ccccc3)C(=O)N)O
InChI	InChI	1.03	InChI=1S/C18H17BN2O6/c20-17(24)16(10-4-2-1-3-5-10)21-18(25)11-6-7-12-13(8-11)19(26)27-14(12)9-15(22)23/h1-8,14,16,26H,9H2,(H2,20,24)(H,21,25)(H,22,23)/t14-,16+/m0/s1
InChIKey	InChI	1.03	IKQIDNCBKATNDV-GOEBONIOSA-N

Related Resource References

Resource Name	Reference
PubChem	156587325

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.